The results showed that MTC could increase the survival rate of nerve cells and protect neurons from ischemic injury by activating PI3K/AKT pathway, inhibit mitochondrial apoptosis signaling pathway, reduce ERS, and activate ERK-MEK signaling pathway. This evidence concerns the gene AKT1 and medullary thyroid gland carcinoma.